SynthesisBMC cancer2024

Relative efficacy of antibody-drug conjugates and other anti-HER2 treatments on survival in HER2-positive advanced breast cancer: a systematic review and meta-analysis.

Zian Kang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.